This study is designed to test the feasibility and preliminary efficacy of a continuous glucose monitor (CGM)-augmented food is medicine (FIM) intervention for adults with type 2 diabetes and nutrition or food insecurity. This study will learn if a FIM intervention ("intervention") that includes access to real-time CGM and nutrition counseling can increase engagement, improve glycemic management, and support healthy eating in this population, compared to the FIM intervention alone ("comparator"). At the study baseline, participants will be randomized to either the intervention or the comparator arm for 16 weeks. The intervention will occur during the first 12 weeks (phase 1: intervention phase) and will be compared to a standard FIM approach without CGM or counseling. Phase 2 (extension phase) will last 4 weeks and will consist of all participants in the intervention and comparator arm receiving both FIM and CGM for self-directed use. The study will also explore participant experiences through a series of semi-structured interviews with a subset of randomly selected participants to identify opportunities for scaling the intervention to a broader population.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in percent of Time in Range (TIR)
Timeframe: Baseline at Week 0, Post-intervention at Week 12
Change in percent of Time Below Range (TBR)
Timeframe: Baseline at Week 0, Post-intervention at Week 12
Change in percent of Time Above Range (TAR)
Timeframe: Baseline at Week 0, Post-intervention at Week 12
Glycemic variability
Timeframe: Baseline at Week 0, Post-intervention at Week 12
Change in Hemoglobin A1c (HbA1c)
Timeframe: Baseline at Week 0, Post-intervention at Week 12
Change in Healthy Eating Index (HEI) Score based on two 24-hour recalls
Timeframe: Baseline at Week 0, Post-intervention at Week 12, Post-extension at Week 16
Change in Mediterranean diet scores
Timeframe: Baseline at Week 0, Post-Intervention at Week 12, Post-extension at Week 16
Change in Dietary Approaches to Stop Hypertension (DASH) Scores
Timeframe: Baseline at Week 0, Post-Intervention at Week 12, Post-extension at Week 16